Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis and to Reduce Medical Utilization in Patients With Gastroparesis
Latest Information Update: 24 Jul 2023
At a glance
- Drugs Granisetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting; Gastroparesis
- Focus Therapeutic Use
- 10 Aug 2020 New trial record